The 4th Webinar in Q Bay Accelerator Program: John E. Dowling talks with N1 LIFE
Event Information
Time:
Dec 17, 2020 at 6:00 PM Pacific Time
Dec 17, 2020 at 9:00 PM Eastern Time
Dec 18 , 2020 at 10:00 AM Beijing Time
Welcome to join us on Zoom:
https://zoom.us/j/93547064577?pwd=WkdqOG5SNkt3eStVK1Y0WUZzbURGUT09
Speaker: John E. Dowling
Professor of Neurosciences at Harvard University
An American neuroscientist well-known for his seminal work in vision science
Member of the Scientific Advisory Board of Research to Prevent Blindness (1991–present)
Member of the Scientific Advisory Board of the Knights Templar Research Foundation (1991–present)
Member of the Scientific Advisory Board of the McLean Hospital (1991–present)
Member of the Educational Advisory Board of the John S. Guggenheim Memorial Foundation (1991–present)
Member of the Board of Directors of the Harvard University Press (1997–present)
President of the Corporation of Marine Biological Laboratory (1998–present)
Elected to the National Academy of Sciences in 1976
A writer with multiply entrepreneurship experience
Startup Pitch:
N1 LIFE
Agenda
6:00 pm-6:05 pm
Opening Remark: Introduction of Q Bay Center
6:05 pm-6:35 pm
Keynote speech from John E. Dowling
6:35 pm-7:15 pm
Startups Pitch from N1 LIFE
7:15 pm-7:30 pm
Q & A
About N1 LIFE
N1 Life is an early-stage biopharma company founded by Stanford scientists and industry leaders focusing on developing new therapeutics to address unmet medical needs. The company is utilizing the patented molecular delivery technology to improve the efficacy of drug candidates, overcome multi-drug resistance, and minimize associated systemic toxicity and side effects. Using N1 Life’s strategy, one can effectively save 40% development time and 75% cost compared to a traditional drug development program. Currently, N1 Life has established multiple pipelines with one anticipated IND filing in 2021. The team is also looking to expand the application of the technology to non-therapeutic uses in order to benefit more people.